Investors | Avacta Life Sciences Limited

Home News Investors

20 Sep 2023

Issue of Equity and Total Voting Rights

20 Sep 2023

Peel Hunt Appointed as Joint Broker

20 Sep 2023

Appointment of Dr. Christina Coughlin as a consultant

Investors | Therapeutics

19 Sep 2023

Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update

Investors | Therapeutics

06 Sep 2023

Notice of Results

21 Jul 2023

Issue of Equity and Total Voting Rights

28 Jun 2023

Result of Annual General Meeting

28 Jun 2023

Annual General Meeting and Shareholder Event

21 Jun 2023

Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

Investors | Therapeutics

19 Jun 2023

Director Appointment